ArticleJournal of clinical medicine2022

Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies.

Agustín Sancho-Saldaña et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.